scholarly journals Retrospective meta-transcriptomic identification of severe dengue in a traveller returning from Africa to Sweden, 1990

2020 ◽  
Author(s):  
Kristian Alfsnes ◽  
Nina Lagerqvist ◽  
Sirkka Vene ◽  
Jon Bohlin ◽  
Jenny Verner-Carlsson ◽  
...  
Keyword(s):  
Dengue Virus ◽  
Rna Sequencing ◽  
Dengue Infection ◽  
Severe Dengue ◽  
Diagnostic Study ◽  
Aetiological Agent ◽  
Haemorrhagic Fever ◽  
Imported Case ◽  
Plasma And Urine Samples ◽  
Retrospective Investigation

The first imported case of severe haemorrhagic fever in Sweden was reported in 1990. Despite extensive diagnostic study, no aetiological agent was identified. Following retrospective investigation with total RNA-sequencing of plasma and urine samples collected during between 7 to 36 days from onset of symptoms, we identified dengue virus 3 (DENV-3) and a human pegivirus (HPgV). We conclude that the patient most likely suffered from haemorrhagic symptoms due to a severe dengue infection.

scholarly journals Simulation Model for Dynamics of Dengue with Innate and Humoral Immune Responses

2018 ◽  
Vol 2018 ◽  
pp. 1-18 ◽  
Author(s):  
S. D. Perera ◽  
S. S. N. Perera
Keyword(s):  
Immune Response ◽  
Immune Responses ◽  
Dengue Virus ◽  
Dengue Infection ◽  
Asymptomatic Infection ◽  
Severe Dengue ◽  
Viral Kinetics ◽  
Humoral Immune ◽  
Humoral Immune Responses ◽  
Kinetics Of

Dengue virus is a mosquito borne Flavivirus and the most prevalent arbovirus in tropical and subtropical regions around the world. The incidence of dengue has increased drastically over the last few years at an alarming rate. The clinical manifestation of dengue ranges from asymptomatic infection to severe dengue. Even though the viral kinetics of dengue infection is lacking, innate immune response and humoral immune response are thought to play a major role in controlling the virus count. Here, we developed a computer simulation mathematical model including both innate and adaptive immune responses to study the within-host dynamics of dengue virus infection. A sensitivity analysis was carried out to identify key parameters that would contribute towards severe dengue. A detailed stability analysis was carried out to identify relevant range of parameters that contributes to different outcomes of the infection. This study provides a qualitative understanding of the biological factors that can explain the viral kinetics during a dengue infection.

scholarly journals Faktor – Faktor Yang Mempengaruhi Kejadian Penyakit Demam Berdarah Dengue (DBD) Dan Jenis Serotipe Virus Dengue Di Kabupaten Semarang

2016 ◽  
Vol 14 (2) ◽  
pp. 51
Author(s):  
Pramudiyo Teguh Sucipto ◽  
Mursid Raharjo ◽  
Nurjazuli Nurjazuli
Keyword(s):  
Dengue Virus ◽  
Physical Environment ◽  
Case Control Study ◽  
Dengue Infection ◽  
Case Control ◽  
Haemorrhagic Fever ◽  
Mosquito Repellent ◽  
Virus Serotype ◽  
Water Container ◽  
Control Study

Background: Dengue infection continues to present a seriuos public health problem.The cases of Dengue Haemorrhagic Fever (DHF) in Semarang District has increased significantly and cause death. The purpose of this study was to determine the factors that affect the incedence of dengue and dengue virus serotype in Semarang Distric.Method : This is case control study using 54 cases and 54 control are people who live around the case with the caracteristics of age one the same with case and sex of the case.The analysis methods applied were univariate and bivariates with chi-squre and multivariate with logistic regression. Results : Risk factors incidence of dengue in Semarang District were humidity in the room (OR = 5.8; 95% CI = 1.322 to 14.170), the eksistence larvae in the water container (OR = 6.6; 95% CI = 2.386 - 18.277), the habit of using anti-mosquito / repellent (OR = 4.4; 95% CI = 1.076 to 8.875), the habit of hanging clothes (OR = 3.9; 95% CI = 1018 to 9.861). Serotype of dengue virus dominant Den-1.Conclusion : The factors that influence the incidence of DHF are the eksistence larvae the water container, the habit of using anti-mosquito / repellent, the habit of hanging clothes and humidity in the room. Serotype of dengue virus dominant is Den-1. Suggestion necessary environmental management by changing physical environment and the DHF program vector Aedes aegypti intervention. Keywords : Dengue Haemorragic Fever, Serotype of  dengue virus

scholarly journals Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children

2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Randula Ranawaka ◽  
Chamara Jayamanne ◽  
Kavinda Dayasiri ◽  
Dinuka Samaranayake ◽  
Udara Sandakelum ◽  
...  
Keyword(s):  
Dengue Fever ◽  
Past History ◽  
Secondary Infection ◽  
Severe Disease ◽  
Dengue Infection ◽  
Dengue Shock Syndrome ◽  
Dengue Haemorrhagic Fever ◽  
Severe Dengue ◽  
Haemorrhagic Fever ◽  
History Of

Pathogenesis of dengue haemorrhagic fever is not fully understood, but it is thought that there is antibody enhancement during the secondary infection, which causes severe dengue haemorrhagic fever (DHF). Therefore, patients who have DHF should have a documented history of symptomatic dengue infection in the past. A retrospective descriptive-analytical study was conducted at the University Paediatric Unit at Lady Ridgeway Hospital for Children, Colombo, Sri Lanka. All children who had fulfilled the criteria for DHF admitted to the unit from April 2018 to September 2018 were recruited into the study. Relevant data were collected from bed head tickets. One hundred and eighty-four children were included in the final analysis. Thirty-three (17.9%) had a past history of documented symptomatic dengue infection, while 82.1% did not have a documented dengue infection. Twelve patients had dengue shock syndrome, and none of them had previously documented symptomatic dengue fever. Dextran was used in 96 patients in the critical phase. Twelve (42%) patients with past documented symptomatic dengue fever needed dextran while 84 (54.9%) patients without a documented past history of dengue fever needed dextran. In our clinical observation, we noticed that children with DHF mostly did not have a documented symptomatic prior dengue infection, while those with a documented symptomatic prior infection had a milder subsequent illness. In fact, the majority (82.1%) of patients with DHF did not have documented previous symptomatic dengue infection. It was also observed that the clinical course of subsequent dengue infection was less severe in patients with previously documented symptomatic dengue fever. This finding should be further evaluated in a larger scale study minimizing the all-confounding factors. This fact is more important in selecting recipients for vaccines against the dengue virus, which are supposed to produce immunity against the virus without causing the severe disease.

scholarly journals 1768. Dengue Virus Infection in Solid-Organ Transplant Recipients: Case Series and Literature Review

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S651-S652
Author(s):  
Fernando Rosso ◽  
Ana M Sanz ◽  
Luis Gabriel Parra-Lara ◽  
Pablo A Moncada ◽  
Juan D Vélez ◽  
...  
Keyword(s):  
Virus Infection ◽  
Literature Review ◽  
Dengue Virus ◽  
Dengue Infection ◽  
Organ Transplant ◽  
Case Series ◽  
Solid Organ Transplant ◽  
Severe Dengue ◽  
Solid Organ ◽  
Dengue Virus Infection

Abstract Background Dengue fever is the most prevalent arbovirus among humans, its incidence has increased since the re-emergence, and Colombia is a hyperendemic country for this infection. The number of solid-organ transplant (SOT) recipients, at risk of acquiring dengue virus infection, is constantly increasing, and there are few data regarding the clinical course and outcomes of dengue infection among this population. The aim of this study was to describe dengue virus infection in SOT recipients in Cali, Colombia. Methods We present a case series of SOT recipients with dengue virus infection, diagnosed by World Health Organization criteria and a positive NS1 and/or IgM dengue antibodies, which were attended at the FVL from 2001 to 2018. Furthermore, we performed a literature review regarding dengue infection in SOT recipients. Results A total of 20 patients were included: 17 kidney and 3 liver recipients. The median age was 50.5 years (IQR = 31–63.5), 65% were female. The median time from transplant to dengue was 27.6 months (IQR = 3.82–59.12), and 3 patients had the infection in the first month after the transplant. The most common symptoms were fever (95%), myalgia, headache, and abdominal pain. Warning signs were present in 75% of patients, thrombocytopenia and hemorrhagic manifestations were present in 30% and 15%, respectively. 35% of patients were classified as severe dengue, and 45% were managed at the intensive care unit. Regarding laboratory findings, six patients had transaminases elevation more than three times the upper limit and 7 had serum creatinine elevation, which returned to normal levels. All patients were discharged and none of them had alterations in the graft function. To date, there are approximately 180 reported cases of dengue in SOT recipients (Table 2). Conclusion Dengue represents a threat among SOT recipients. Unlike other reports, all patients in this series had a full recovery after the infection, suggesting that timely and effective management of patients and the access to high complexity services could prevent fatal cases. Disclosures All authors: No reported disclosures.

scholarly journals A Non Mouse-Adapted Dengue Virus Strain as a New Model of Severe Dengue Infection in AG129 Mice

2010 ◽  
Vol 4 (4) ◽  
pp. e672 ◽  
Author(s):  
Grace K. Tan ◽  
Jowin K. W. Ng ◽  
Scott L. Trasti ◽  
Wouter Schul ◽  
George Yip ◽  
...  
Keyword(s):  
Dengue Virus ◽  
Virus Strain ◽  
Dengue Infection ◽  
Severe Dengue ◽  
New Model

scholarly journals Dengue Fever: Clinical, Laboratory Profile and Outcome in Pediatric Patient

2022 ◽  
Vol 6 (1) ◽  
Author(s):  
Pooja Gandhi ◽  
Pinkal Taral ◽  
Krunal Patel ◽  
Sanketsinh Rathod ◽  
Bhavini Rathwa
Keyword(s):  
Platelet Count ◽  
Dengue Virus ◽  
Dengue Fever ◽  
Care Center ◽  
Dengue Infection ◽  
Tertiary Care ◽  
Clinical Profile ◽  
Severe Dengue ◽  
Diverse Range ◽  
Laboratory Profile

Introduction: Infection with any of the 4 dengue virus serotypes results in a diverse range of symptoms, from mild undifferentiated fever to life-threatening hemorrhagic fever and shock. Given that dengue virus infection elicits such a broad range of clinical symptoms, early and accurate laboratory diagnosis is essential for appropriate patient management. So a study was carried out to know its clinical profile, correlation between the laboratory profile and the severity of dengue fever and outcome in dengue patients. Aim: To study the clinical profile, correlation between the laboratory profile and the severity of dengue fever and outcome in dengue patients at tertiary care center. Method: Retrospective Observational study from 1st May 2019 to 31st April 2021. Result: Total 323 patients were studied during 1st May 2019 to 31st April 2021. Most common presentation was fever (100%), most common clinical finding is hepatomegaly (14.2%). All severe dengue infection has platelet count < 50000/cumm. In study of 323 patients 194(60%) of dengue fever,85(26.4%) of DHF GRADE 1,9(2.8%) of DHF GRADE 2 were discharged .13(4%) patients of DSS were expired.22 patients (6.8%) went DAMA. Conclusion: Reliable diagnosis of dengue fever in endemic areas can be done by clinical parameters like presence of nausea, vomiting, pain abdomen and hepatomegaly. Monitoring platelet count, hematocrit and WBC count is very useful for management of dengue cases. Keywords: dengue fever, platelet count, outcome

Discovery of Dengue Virus Inhibitors

2020 ◽  
Vol 27 (30) ◽  
pp. 4945-5036 ◽  
Author(s):  
Adib Afandi Abdullah ◽  
Yean Kee Lee ◽  
Sek Peng Chin ◽  
See Khai Lim ◽  
Vannajan Sanghiran Lee ◽  
...  
Keyword(s):  
Dengue Virus ◽  
Drug Targets ◽  
Protective Efficacy ◽  
Dengue Infection ◽  
Viral Proteins ◽  
Host Factors ◽  
Structural Proteins ◽  
Severe Dengue ◽  
Dengue Vaccine

To date, there is still no approved anti-dengue agent to treat dengue infection in the market. Although the only licensed dengue vaccine, Dengvaxia is available, its protective efficacy against serotypes 1 and 2 of dengue virus was reported to be lower than serotypes 3 and 4. Moreover, according to WHO, the risk of being hospitalized and having severe dengue increased in seronegative individuals after they received Dengvaxia vaccination. Nevertheless, various studies had been carried out in search of dengue virus inhibitors. These studies focused on the structural (C, prM, E) and non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) of dengue virus as well as host factors as drug targets. Hence, this article provides an overall up-to-date review of the discovery of dengue virus inhibitors that are only targeting the structural and non-structural viral proteins as drug targets.

scholarly journals High Expression of FcγII (CD32) Receptor on Monocytes in Dengue Infected Patients

2018 ◽  
Vol 10 (3) ◽  
pp. 256-62
Author(s):  
Umi Solekhah Intansari ◽  
Harina Salim ◽  
Usi Sukorini ◽  
Adika Zhulhi Arjana ◽  
Muhammad Juffrie
Keyword(s):  
Flow Cytometry ◽  
Dengue Virus ◽  
Healthy Subjects ◽  
Dengue Infection ◽  
Absolute Number ◽  
Severe Dengue ◽  
Cross Sectional ◽  
Fluorescent Intensity ◽  
The Mean ◽  
Cross Sectional Design

BACKGROUND: Pathogenesis of severe dengue infection has not been elucidated. Immune complex of pre-existing antibodies and heterotypic dengue virus bind to FcγII (cluster of differentiation (CD32)) receptor (FcγIIR) on monocyte facilitates entry and replication of dengue virus. Aim of this study was to evaluate the expression of FcγIIR on monocytes in patients infected with dengue and in healthy subjects.METHODS: This study used a cross-sectional design that included patients infected with dengue who were hospitalized in Dr. Sardjito General Hospital, Panembahan Senopati Hospital, and Sleman Hospital, who met the inclusion criteria and selected consecutively. Examinations were completed using a lyse, no-wash method of flow cytometry. Computerized statistical analysis was conducted and was considered to be significant if p<0.05.RESULTS: Sixty-five study subjects were divided into healthy subjects (24 subjects) and patients with dengue infection (41 subjects). There were no significant differences in hemoglobin (Hb) and hematocrit (Hct) values between the groups, but differences were found in the number of leukocytes, absolute number of monocytes and platelet count (p<0.001, 0.002 and <0.001, respectively). The mean expression of FcγIIR monocytes in patients with dengue infection (208.77±32.06 median fluorescent intensity (MFI)) and the healthy subjects (124.03±47.76 MFI) with p<0.0001.CONCLUSION: The mean expression of FcγIIR monocytes in patients with dengue infection was higher than in healthy subjects.KEYWORDS: dengue infection, FcγII (CD32) receptor monocyte, flow cytometry

scholarly journals Epidemiology Study of Dengue Virus In Surabaya, Bogor, and Bangkalan, Indonesia 2008-2018

2020 ◽  
Vol 56 (4) ◽  
pp. 296
Author(s):  
Soegeng Soegijanto ◽  
Teguh Hari Sucipto ◽  
Kris Cahyo Mulyatno ◽  
Siti Churrotin
Keyword(s):  
Infectious Disease ◽  
Dengue Virus ◽  
Collaborative Research ◽  
Dengue Infection ◽  
Research Network ◽  
Viral Diseases ◽  
Haemorrhagic Fever ◽  
Epidemiology Study ◽  
Virus Surveillance ◽  
Infection Disease

Dengue virus (DENV) is mosquito-borne viral diseases, transmitted by the vector mosquitoes such as Aedes sp. Infection with four serotypes of DENV-1 to 4. Indonesia, dengue haemorrhagic fever (DHF) was first recognized in 1968 in the cities of Jakarta and Surabaya. In 2007, we started DENV surveillance in Surabaya supported by the joined program of the Japan Initiative for Global Research Network on Infectious Disease (J-GRID) established the Indonesia-Kobe University Collaborative Research Center for Emerging and Reemerging Infectious Diseases (CRC-ERID). The results of serotype and genotype, in Surabaya and Bangkalan are similar with previous result in Indonesia, but especially in Bogor similar with Japan 2014. This study showed the importance of continuous virus surveillance in dengue endemic areas, in order to understand the dynamic of dengue infection disease in Indonesia.

scholarly journals Dengue!!! A Current Threat with Previous Experience

2019 ◽  
pp. 1
Author(s):  
Sadia Choudhury Shimmi ◽  
Mohd Yusuf Ibrahim ◽  
Kamruddin Ahmed
Keyword(s):  
Dengue Virus ◽  
Rna Virus ◽  
Dengue Shock Syndrome ◽  
Warning Signs ◽  
Dengue Haemorrhagic Fever ◽  
Musculoskeletal Symptoms ◽  
Severe Dengue ◽  
Infected Person ◽  
Haemorrhagic Fever ◽  
Infected Female

Dengue is a global health problem. Some countries describe it as ‘endemic’ where other countries as 'epidemic' according to the prevalence of the disease1. Dengue virus transmitted by the infected female Aedes aegypti and Aedes albopictus mosquitoes, belongs to the genus Flavivirus which is an envelope positive-sense single-stranded RNA virus. Rainy season (June to October) is the prime time of spreading the infection in Southeast Asia. Four serotypes of dengue viruses (DEN1, DEN-2, DEN-3 and DEN-4) are able to infect humans and cause dengue haemorrhagic fever/dengue shock syndrome like severe infections. Moreover, cross-reactive antibodies (IgM and IgG) produce against other serotype when infection occurs with one serotype. This is one of the diagnostic problem for acute dengue2. Some researchers experienced that without warning signs and mild symptoms were found in DEN-1, severe dengue was found in DEN-2 patients as compared to other serotypes and musculoskeletal symptoms were prominent in DEN-3 infected patients. So that different receptors or organs are targeted to establish infection by different dengue serotypes3. This virus circulates in the blood of an infected person for 2 – 7 days, at that time the infected person develops a fever. After appearance of the first symptoms (for 4 – 5 days; maximum 12 days), infected patients can transmit the infection via Aedes mosquitoes1 dengue virus infection in humans ranging from clinically asymptomatic or transient nonspecific febrile illness to classical dengue fever (DF) and dengue haemorrhagic fever/ dengue shock syndrome (DHF/ DSS). Fever, headache, rash, bone and muscle pains with or without abdominal pain are the general clinical presentation of patients with DF and early DHF/DSS. Haemorrhagic manifestations such as haematuria, bleeding gums, epistaxis, hematemesis, melena, and ecchymosis develop in DHF. DHF patients develop thrombocytopaenia and haemoconcentration. Some patients may progress into DSS, leading to profound shock and death if not diagnosed or treated properly2.

Sign in / Sign up

Export Citation Format

Share Document